Search Results Search Sort by RelevanceMost Recent Case and Commentary Aug 2003 Spare the Rod and Save the Child, Commentary 2 Arthur F. Kohrman, MD Virtual Mentor. 2003;5(8):305-307. doi: 10.1001/virtualmentor.2003.5.8.ccas2-0308. State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511. Case and Commentary Dec 2020 How Should Clinicians Respond When Patients’ Loved Ones Do Not See “Brain Death” as Death? Rabbi Jason Weiner, DBioethics and Rabbi Charles Sheer, MA, BCC Religious and cultural values can conflict with clinical standard practice and law. AMA J Ethics. 2020;22(12):E995-1003. doi: 10.1001/amajethics.2020.995. Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. AMA Code Says Dec 2020 AMA Code of Medical Ethics' Opinions About End-of-Life Care and Death Danielle Hahn Chaet, MSB This article considers relevant history that informs the AMA Code of Medical Ethics' opinions about neurological criteria for death. AMA J Ethics. 2020;22(12):E1025-1026. doi: 10.1001/amajethics.2020.1025. Podcast Nov 2020 Ethics Talk: Managing Health Care AI “Megarisks” Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves. State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601. Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607. Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last »
Case and Commentary Aug 2003 Spare the Rod and Save the Child, Commentary 2 Arthur F. Kohrman, MD Virtual Mentor. 2003;5(8):305-307. doi: 10.1001/virtualmentor.2003.5.8.ccas2-0308.
State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511.
Case and Commentary Dec 2020 How Should Clinicians Respond When Patients’ Loved Ones Do Not See “Brain Death” as Death? Rabbi Jason Weiner, DBioethics and Rabbi Charles Sheer, MA, BCC Religious and cultural values can conflict with clinical standard practice and law. AMA J Ethics. 2020;22(12):E995-1003. doi: 10.1001/amajethics.2020.995.
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
AMA Code Says Dec 2020 AMA Code of Medical Ethics' Opinions About End-of-Life Care and Death Danielle Hahn Chaet, MSB This article considers relevant history that informs the AMA Code of Medical Ethics' opinions about neurological criteria for death. AMA J Ethics. 2020;22(12):E1025-1026. doi: 10.1001/amajethics.2020.1025.
Podcast Nov 2020 Ethics Talk: Managing Health Care AI “Megarisks” Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601.
Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607.
Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613.